Log In
BCIQ
Print this Print this
 

NP03

  Manage Alerts
Collapse Summary General Information
Company Medesis Pharma
DescriptionLithium citrate tetrahydrate delivered using Aonys buccal reverse-micelle formulation technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHuntington's disease (HD)
Indication DetailsTreat Huntington's disease (HD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today